Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) shares up in the sky after this update
Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) stock soared 17.36% to $1.42 in the pre-market trading session following an announcement by a biopharmaceutical corporation focusing on advancing immunology-based treatments for common inflammatory disorders that two collaboration have been reached to explore potential therapeutic applications for its immunomodulatory drug, Ampion. The Organization has entered into a cooperative […]
Why Ocugen, Inc. (NASDAQ: OCGN) share price is going above the radar
Ocugen, Inc. (NASDAQ: OCGN), shares jumped 16.96% to $0.34 in the premarket session after, a biopharmaceutical firm focusing on the exploration, development, and commercialization of innovative therapies for the treatment of blindness diseases, recently confirmed that it would delay its 2020 Annual Meeting of Stockholders to December 23, 2020, to allow more time for its […]
Will it be the right move to capitalize on ARRAY TECHNOLOGIES (NASDAQ: ARRY)?
According to the information given by S&P Global Market Intelligence, ARRAY TECHNOLOGIES (NASDAQ: ARRY) shares have risen by 23.7% in November. The adjusted net income for Array was $0.07 per share, with the third-quarter net loss being $7.2 million ($0.06 per share) and revenue is $139.5 million. Since Array also announced a share offering, the […]
